RPG Life Sciences spends Rs.215 crore on two API makers
RPG Life Sciences has spent Rs.215 crore to buy two active pharmaceutical ingredient (API) makers within five weeks and is continuing with a further Rs.700 crore plan, per TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.